Quick Answer
Xtant Medical Holdings, Inc. reported Research And Development Expense of $2.10 million for the year ending 2025.
- Xtant Medical Holdings, Inc. showed a decrease of -11.9% in Research And Development Expense from 2024 to 2025.
- This data is from Xtant Medical Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Xtant Medical Holdings, Inc.'s Research And Development Expense has grown by 267.3%.
- Historical annual values: Fiscal year 2025: $2.10 million | Fiscal year 2024: $2.39 million | Fiscal year 2023: $1.34 million | Fiscal year 2022: $915.0 thousand | Fiscal year 2021: $870.0 thousand | Fiscal year 2020: $657.0 thousand | Fiscal year 2019: $932.0 thousand | Fiscal year 2018: $1.70 million | Fiscal year 2017: $2.44 million | Fiscal year 2016: $3.41 million | Fiscal year 2015: $2.55 million | Fiscal year 2014: $1.44 million | Fiscal year 2013: $572.4 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: